Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice. Beasley, R., Harper, J., & Masoli, M. The Lancet Respiratory Medicine, 8(5):425–427, May, 2020.
Paper doi bibtex @article{beasley_anti-interleukin-5_2020,
title = {Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice},
volume = {8},
issn = {22132600},
shorttitle = {Anti-interleukin-5 therapy in patients with severe asthma},
url = {https://linkinghub.elsevier.com/retrieve/pii/S2213260020300515},
doi = {10.1016/S2213-2600(20)30051-5},
language = {en},
number = {5},
urldate = {2021-05-07},
journal = {The Lancet Respiratory Medicine},
author = {Beasley, Richard and Harper, James and Masoli, Matthew},
month = may,
year = {2020},
pages = {425--427},
}
Downloads: 0
{"_id":"WCJCXxiHB4WPKMDK4","bibbaseid":"beasley-harper-masoli-antiinterleukin5therapyinpatientswithsevereasthmafromclinicaltrialstoclinicalpractice-2020","author_short":["Beasley, R.","Harper, J.","Masoli, M."],"bibdata":{"bibtype":"article","type":"article","title":"Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice","volume":"8","issn":"22132600","shorttitle":"Anti-interleukin-5 therapy in patients with severe asthma","url":"https://linkinghub.elsevier.com/retrieve/pii/S2213260020300515","doi":"10.1016/S2213-2600(20)30051-5","language":"en","number":"5","urldate":"2021-05-07","journal":"The Lancet Respiratory Medicine","author":[{"propositions":[],"lastnames":["Beasley"],"firstnames":["Richard"],"suffixes":[]},{"propositions":[],"lastnames":["Harper"],"firstnames":["James"],"suffixes":[]},{"propositions":[],"lastnames":["Masoli"],"firstnames":["Matthew"],"suffixes":[]}],"month":"May","year":"2020","pages":"425–427","bibtex":"@article{beasley_anti-interleukin-5_2020,\n\ttitle = {Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice},\n\tvolume = {8},\n\tissn = {22132600},\n\tshorttitle = {Anti-interleukin-5 therapy in patients with severe asthma},\n\turl = {https://linkinghub.elsevier.com/retrieve/pii/S2213260020300515},\n\tdoi = {10.1016/S2213-2600(20)30051-5},\n\tlanguage = {en},\n\tnumber = {5},\n\turldate = {2021-05-07},\n\tjournal = {The Lancet Respiratory Medicine},\n\tauthor = {Beasley, Richard and Harper, James and Masoli, Matthew},\n\tmonth = may,\n\tyear = {2020},\n\tpages = {425--427},\n}\n\n","author_short":["Beasley, R.","Harper, J.","Masoli, M."],"key":"beasley_anti-interleukin-5_2020","id":"beasley_anti-interleukin-5_2020","bibbaseid":"beasley-harper-masoli-antiinterleukin5therapyinpatientswithsevereasthmafromclinicaltrialstoclinicalpractice-2020","role":"author","urls":{"Paper":"https://linkinghub.elsevier.com/retrieve/pii/S2213260020300515"},"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://api.zotero.org/users/6607533/collections/EUK4Z2Y3/items?key=hGXLq241MCQA3ow7rlTIV2gY&format=bibtex&limit=100","dataSources":["g6GzqSeiNQrL4uwxq","x3a5YBvn82E6RBLXv","CfMcCM7QT97iZEsTA","rhgC4BmfWie6Lm3F7"],"keywords":[],"search_terms":["anti","interleukin","therapy","patients","severe","asthma","clinical","trials","clinical","practice","beasley","harper","masoli"],"title":"Anti-interleukin-5 therapy in patients with severe asthma: from clinical trials to clinical practice","year":2020}